World's first CRISPR-based medicine wins approval in U.K
Published
LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine. The authorization of the…
#crispr #crisprtherapeutics #healthcare #regulatoryagency #mhra